HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 1071 | 1284 | 83.4% | |
| HF 4 | 2011 | 1131 | 1350 | 83.8% | |
| HF 4 | 2012 | 1174 | 1415 | 83.0% | |
| HF 4 | 2013 | 1235 | 1421 | 86.9% | |
| HF004(S) | 2014 | 407 | 436 | 93.3% | |
| HF004(S) | 2015 | 686 | 718 | 95.5% | |
| HF004(S) | 2016 | 1105 | 1170 | 94.4% |
